The same group reported that knockdown of UBC9 in BRCA1 mutant triple-negative breast cancer and HGSOC cells inhibited cell proliferation and migration, indicating the pivotal role of UBC9 in endothelial-mesenchymal transition in such cancer type [34]. This evidence concerns the gene UBE2I and triple-negative breast carcinoma.